Abbott Agrees to Pay Over $384M to Settle Allegations Related to Contaminated Infant Formula
- DOJ 近 90 天出现 1117 次
- DOJ 近 90 天第 202 次法务
- 上一次:1 天前 · Federal grand jury indicts four in two related fraud schemes targeting elderly and vulnerable victims
发生了什么
Abbott Laboratories (Abbott), an Illinois-based healthcare company that manufactures and sells infant formula and nutritional therapy products, has agreed to pay $384,999,040 to resolve allegations that it caused false claims to be submitted between Jan. 1, 2018, and Dec. 31, 2022, to federal and state programs arising from its failure to manufacture certain powder infant
摘要按规则整理自下方来源原文